Cryptococcosis in colombia: Results of the national surveillance program for the years 2006-2010

Biomedica

Volumn 32, Issue 3, 2012, Pages 386-398

  Escandón, Patricia ^a   de Bedout, Catalina ^b   Lizarazo, Jairo ^c   Agudelo, Clara Inés ^a   Tobón, Ángela ^b   Bello, Solmara ^a   Restrepo, Ángela ^b   Castañeda, Elizabeth ^a  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b Corporación para Investigaciones Biológicas ^*  (Colombia)

^c Hospital Universitario Erasmo Meoz   (Colombia)

Author keywords

Acquired immunodeficiency Syndrome; Colombia.; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Morbidity; Mortality

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGUS ANTIGEN;

ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; BLOOD; CHILD; COLOMBIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; RETROSPECTIVE STUDY; SYMPTOM ASSESSMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; CHILD; COLOMBIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, MULTIPLE, FUNGAL; FEMALE; FLUCONAZOLE; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SYMPTOM ASSESSMENT; YOUNG ADULT;

CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS VAR. GRUBII; CRYPTOCOCCUS NEOFORMANS VAR. NEOFORMANS; FILOBASIDIELLA NEOFORMANS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84877035122     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: 10.7705/biomedica.v32i3.707     Document Type: Article

References (48)

1. Velagapudi R, Hsueh YP, Geunes-Boyer S, Wright JR, Heitman J. Spores as infectious propagules of Cryptococcus neoformans. Infect Immun. 2009;77:4345-55. http://dx.doi.org/10.1128/IAI.00542-09
2. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: Separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol. 1999;37:838-40.
3. Kwon-Chung KJ, Varma A. Do major species concept supports one, two or more species within Cryptococcus neoformans? FEMS Yeast Res. 2006;6:574-87. http://dx.doi.org/10.1111/j.1567-1364.2006.00088.x
4. Bovers M, Hagen F, Kuramae EE, Díaz MR, Spanjaard L, Dromer F et al. Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res. 2006;6:599-607. http://dx.doi.org/10.1111/j.1567-1364.2006.00082.x
5. Bovers M, Hagen F, Kuramae EE, Hoogveld HL, Dromer F, St-Germain G, et al. AIDS patient death caused by novel Cryptococcus neoformans × C. gattii hybrid. Emerg Infect Dis.2008;14:1105-8.http://dx.doi.org/10.3201/eid1407.080122
6. Byrnes EJ 3rd, Barlett K, Perfect J, Heitman J. Cryptococcus gattii: An emerging fungal pathogen infecting humans and animals. Microbes Infect. 2011;13:895-907. http://dx.doi.org/10.1016/j.micinf.2011.05.009
7. Pongsai P, Atamasirikul K, Sungkanuparph S. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. J Infect. 2010;60:474-7. http://dx.doi.org/10.1016/j.jinf.2010.03.015
8. Levitz SM, Boekhout T. Cryptococcus: The once-sleeping giant is fully awake. FEMS Yeast Res. 2006;6:461-2. http://dx.doi.org/10.1111/j.1567-1364.2006.00113.x
9. Jarvis JN, Boulle A, Loyse A, Bicanic T, Rebe K, Williams A, et al. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS. 2009;23:1182-3. http://dx.doi.org/10.1097/QAD.0b013e32832be0fc
10. Uribe P, Restrepo A, Díaz G. Estudio prospectivo clínico y microbiológico de las meningitis subagudas y crónicas. Antioquia Médica. 1973;23:153-64.
11. Greer DL, de Polanía LA. Criptococosis en Colombia: resumen de la literatura y presentación de doce casos en el Valle del Cauca. Acta Méd Valle. 1977;8:160-6.
12. Vergara I, Saavedra M, Saravia J, González G, Lorenzana P, Acosta C, et al. Criptococosis del sistema nervioso central. Estudio de 32 casos 1975-1991. Acta Méd Colomb. 1992;8:134-41.
13. Lizarazo J, Rodríguez MC. Ordóñez N, Vargas JJ, Castañeda N. Meningitis por Cryptococcus en el Hospital Erasmo Meoz de Cúcuta. Acta Neurol Colomb. 1995;11:259-67.
14. Ordóñez N, Torrado E, Castañeda E. Criptococosis meníngea de 1990 a 1995. Hallazgos de laboratorio. Biomédica. 1996;16:93-7.
15. Lizarazo J, Mendoza M, Palacios D, Vallejo A, Bustamante A, Ojeda E, et al. Criptococosis ocasionada por Cryptococcus neoformans variedad gattii. Acta Méd Colomb. 2000;25:171-8.
16. Lizarazo J, Linares M, de Bedout C, Restrepo A, Agudelo CI, Castañeda E, et al. Estudio clínico y epidemiológico de la criptococosis en Colombia: resultados de nueve años de la encuesta nacional, 1997-2005. Biomédica. 2007;27:94-109.
17. Viviani MA. Epidemiological working groups of ECMM. Mycology Newsletter. 1997;2:4-5.
18. Departamento Nacional de Estadísticas, Dane. Proyecciones de población. Fecha de consulta: 16 de septiembre 2011. Disponible en: http://www.dane.gov.co/index.php?option=com_content&view=article&id=75&Itemid=72
19. Instituto Nacional de Salud. Operación y mantenimiento del sistema de vigilancia y control en salud pública. Informe de VIH-SIDA Colombia período XII año 2010. BogotÁ: Instituto Nacional de Salud; 2010. p. 13.
20. Ordóñez N, Castañeda E. Serotipificación de aislamientos clínicos y del medio ambiente de Cryptococcus neoformans en Colombia. Biomédica. 1994;14:131-9.
21. Kwon-Chung KJ, Polacheck I, Bennet JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol. 1982;5:535-7.
22. Clinical and Laboratory Standards Institute. Method for antifungal disk diffusion susceptibility testing of yeast. Approved guideline M44-A.2004. Wayne, Pa: Clinical and Laboratory Standards Institute; 2004.
23. Barry A, Brown SD. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J Clin Microbiol. 1996;34:2154-7.
24. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23:525-30. http://dx.doi.org/10.1097/QAD.0b013e328322ffac
25. Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: A 9-year survey (1985-1993). French Cryptococcosis Study Group. Clin Infect Dis. 1996;23:82-90. http://dx.doi.org/10.1093/clinids/23.1.82
26. Sorvillo F, Beall G, Turner PA, Beer VL, Kovacs AA, Kerndt PR. Incidence and factors associated with extrapulmonary cryptoccosis among persons with HIV infection in Los Angeles County. AIDS. 1997;11:673-9.
27. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al. Cryptococcosis: Population based multistate active surveillance and risk factors in human immunodeficiency virus infected persons. J Infect Dis. 1999;179:449-54. http://dx.doi.org/10.1086/314606
28. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: An update from population based active surveillance in two large metropolitan areas, 1992-2000. Clin Infect Dis. 2003;36:789-94. http://dx.doi.org/10.1086/368091
29. McCarthy KM, Morgan J, Wannemuehler KA, Mirza SA, Gould SM, Mhlongo N, et al. Population based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. AIDS. 2006;20:2199-206. http://dx.doi.org/10.1097/QAD.0b013e3280106d6a
30. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995;21:28-34. http://dx.doi.org/10.1093/clinids/21.1.28
31. Galanis E, MacDougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis. 2010;16:251-7. http://dx.doi.org/10.3201/eid1602.090900
32. Colom MF, Frasés S, Ferrer C, Martín-Mazuelos E, Hermoso-de-Mendoza M, Torres-Rodríguez JM, et al. Estudio epidemiológico de la criptococosis en España: primeros resultados. Rev Iberoamer Micol. 2001;18:99-104.
33. Darzé C, Lucena R, Gomes I, Melo A. Características clínicas e laboratoriais de 104 casos de meningoencefalite criptocócica. Rev Soc Bras Med Trop. 2000;33:21-6. http://dx.doi.org/10.1590/S0037-86822000000100003
34. Lindenberg A de S, Chang MR, Paniago AM, Lazéra M dos S, Moncada PM, Bonfim GF, et al. Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso Do Sul, Brazil. Rev Inst Med Trop Sao Paulo. 2008;50:75-8. http://dx.doi.org/10.1590/S0036-46652008000200002
35. Pappalardo MC, Melhem MS. Cryptococcosis: A review of the Brazilian experience for the disease. Rev Inst Med Trop Sao Paulo. 2003;45:299-305. http://dx.doi.org/10.1590/S0036-46652003000600001
36. Moreira T, Ferreira MS, Ribas RM, Borges AS. Criptococose: estudo clínico- epidemiológico, laboratorial e das variedades do fungo em 96 pacientes. Rev Soc Bras Med Trop. 2006;39:255-8. http://dx.doi.org/10.1590/S0037-86822006000300005
37. Miglia KJ, Govender NP, Rossouw J, Meiring S, Mitchell TG, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. Analysis of pediatric isolates of Cryptococcus neoformans from South Africa. J Clin Microbiol. 2001;49:307-14. http://dx.doi.org/10.1128/JCM.01277-10
38. Speed BR, Kaldor J. Rarity of cryptococcal infection in children. Pediatr Infect Dis J. 1997;16:536-7.
39. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski LA, Niang R, et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics. 2001;107:E66. http://dx.doi.org/10.1542/peds.107.5.e66
40. MacDougall L, Kidd SE, Galanis E, Mak S, Leslie MJ, Cieslak PR, et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis. 2007;13:42-50. http://dx.doi.org/10.3201/eid1301.060827
41. Pasqualotto AC, Bittencourt Severo C, de Mattos Oliveira F, Severo LC. Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent. Rev Iberoam Micol. 2004;21:143-6.
42. Rozenbaum R, Goncalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis. 1994;18:369-80. http://dx.doi.org/10.1093/clinids/18.3.369
43. Robinson PA, Bauer M, Leal MA, Evans SG, Holtom PD, Diamond DA, et al. Early mycological treatment failure in AIDS associated cryptococcal meningitis. Clin Infect Dis. 1999;28:82-92. http://dx.doi.org/10.1086/515074
44. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey P, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS associated cryptococcal meningitis. N Engl J Med. 1992;326:83-9.
45. Antinori S, Galimberti L, Magni C, Casella A, Vago L, Mainini F, et al. Cryptococcus neoformans infection in a cohort of Italian AIDS patients: Natural history, early prognostic parameters and autopsy findings. Eur J Clin Microbiol Infect Dis. 2001;20:711-7. http://dx.doi.org/10.1007/s100960100616
46. Lizarazo J, Peña Y, Chaves, Omaña R, Huérfano S, Castañeda E. Diagnóstico temprano de la criptococosis y la histoplasmosis en pacientes que viven con el sida. Informe preliminar. Inf Quinc Epidemiol Nac. 2002;7:453-8.
47. Lindsley MD, Nanthawan M, Baggett HC, Surinthong Y, Autthateinchai R, Sawatwong P, et al. Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis. 2011;53:321-5. http://dx.doi.org/10.1093/cid/cir379
48. Pappas G. Cryptococcosis in the developing world: An elephant in the parlor. Clin Infect Dis. 2010;50:345-6. http://dx.doi.org/10.1086/649862